0001989478-25-000001.txt : 20250826 0001989478-25-000001.hdr.sgml : 20250826 20250826154525 ACCESSION NUMBER: 0001989478-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250826 DATE AS OF CHANGE: 20250826 EFFECTIVENESS DATE: 20250826 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Superluminal Medicines, Inc. CENTRAL INDEX KEY: 0001989478 ORGANIZATION NAME: EIN: 883006168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-555850 FILM NUMBER: 251257131 BUSINESS ADDRESS: STREET 1: 15 NECCO ST. STREET 2: LILLY GATEWAY LABS, 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: (301) 525-8752 MAIL ADDRESS: STREET 1: 15 NECCO ST. STREET 2: LILLY GATEWAY LABS, 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0708 D LIVE 0001989478 Superluminal Medicines, Inc. 15 NECCO ST. LILLY GATEWAY LABS, 4TH FLOOR BOSTON MA MASSACHUSETTS 02110 (301) 525-8752 DELAWARE Superluminal Medicines, LLC None Corporation true 2023 CONY D'CRUZ c/o SUPERLUMINAL MEDICINES 15 Necco St, Lilly Gateway Labs, 4th Fl BOSTON MA MASSACHUSETTS 02210 Executive Officer Director Promoter ANDREW LEVIN c/o SUPERLUMINAL MEDICINES 15 Necco St, Lilly Gateway Labs, 4th Fl BOSTON MA MASSACHUSETTS 02210 Director DYLAN MORRIS c/o SUPERLUMINAL MEDICINES 15 Necco St, Lilly Gateway Labs, 4th Fl BOSTON MA MASSACHUSETTS 02210 Director DIAMANTIS XYLAS c/o SUPERLUMINAL MEDICINES 15 Necco St, Lilly Gateway Labs, 4th Fl BOSTON MA MASSACHUSETTS 02210 Director Biotechnology Decline to Disclose 06b false 2025-08-14 false true true Convertible promissory note and the securities issuable upon conversion thereof. false 0 5000000 5000000 0 false 1 0 0 0 false Superluminal Medicines, Inc. /s/ Cony DCruz Cony DCruz Chief Executive Officer 2025-08-26